title: Hyperforin activates nonselective cation channels (NSCCs).
abstract: A large body of evidence supports the preclinical antidepressant profile of hyperforin including inhibition of the synaptosomal uptake of several neurotransmitters by hyperforin and studies in behavioural models. In contrast to other antidepressants, hyperforin does not directly inhibit neurotransmitter transporters, but instead uptake inhibition seems to be the consequence of an elevated intracellular sodium concentration ([Na+]i). The mechanism of hyperforin-induced elevation of [Na+]i was investigated using two different cell types: human platelets and rat pheochromocytoma cells (PC12 cells). In both cell systems, hyperforin increased both [Na+]i and free intracellular Ca2+ concentration ([Ca2+]i). One pathway for Na+ and Ca2+ entry is mediated by nonselective cation channels (NSCCs), which can be blocked by SK&F 96365 and LOE 908. LOE 908 is a blocker of both NSCC1 and NSCC2 subclasses, while SK&F 96365 blocks NSCC2 only. Both SK&F 96365 and LOE 908 completely inhibited the hyperforin-induced influx of Na+ and Ca2+ into platelets and PC12 cells. This indicates that hyperforin is mainly active upon NSCC2. The effect of hyperforin is inhibited by La3+ and Gd3+, indicating that there is a potential homology with canonical transient receptor potential protein channels (TRPC channels). Moreover, La3+ and Gd3+ attenuate the effect of hyperforin on serotonin uptake in human platelets. Additionally, hyperforin induces barium influx in PC12 cells and this influx can be inhibited by SK&F 96365, LOE 908, Gd3+ and La3+. In summary, these findings suggest that hyperforin represents a new principle for preclinical antidepressant activity, modulating brain neurotransmission by inhibition of neurotransmitter uptake via activation of NSCCs.British Journal of Pharmacology (2005) 145, 75-83. doi:10.1038/sj.bjp.0706155.
authors.affiliation: Department of Pharmacology, Biocenter, N260, University of Frankfurt, Marie-Curie-Str. 9, 60439 Frankfurt, Germany.
authors.forename: Kristina
authors.initials: K
authors.lastname: Treiber
authors.forename: Andrea
authors.initials: A
authors.lastname: Singer
authors.forename: Bettina
authors.initials: B
authors.lastname: Henke
authors.forename: Walter E
authors.initials: WE
authors.lastname: Müller
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D002460:Cell Line; D006801:Humans; D007473:Ion Channels / Q000187:drug effects* / Q000378:metabolism; D010696:Phloroglucinol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D019831:Sodium-Calcium Exchanger / Q000187:drug effects / Q000378:metabolism; D013729:Terpenes / Q000494:pharmacology*
chemical_list: D000928:Antidepressive Agents; D001643:Bridged Bicyclo Compounds; D007473:Ion Channels; D010696:Phloroglucinol; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D019831:Sodium-Calcium Exchanger; D013729:Terpenes; C001654:hyperforin
references.citation: Br J Pharmacol. 2002 Aug;136(7):1015-22
references.pmid: 12145101
references.citation: J Pharmacol Exp Ther. 2002 May;301(2):714-9
references.pmid: 11961077
references.citation: J Neurosci. 2002 Nov 1;22(21):9453-64
references.pmid: 12417670
references.citation: Psychopharmacology (Berl). 2002 Dec;164(4):423-8
references.pmid: 12457273
references.citation: J Biol Chem. 2003 Feb 7;278(6):3562-71
references.pmid: 12456670
references.citation: Life Sci. 2003 Jun 13;73(4):461-70
references.pmid: 12759140
references.citation: Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S148-51
references.pmid: 11518066
references.citation: J Neurosci. 2003 Jul 16;23(15):6215-22
references.pmid: 12867505
references.citation: Biochem Pharmacol. 2003 Dec 1;66(11):2177-84
references.pmid: 14609742
references.citation: Nature. 2003 Dec 4;426(6966):517-24
references.pmid: 14654832
references.citation: Br J Pharmacol. 2004 Jun;142(3):414-8
references.pmid: 15148244
references.citation: Annu Rev Biochem. 1983;52:871-926
references.pmid: 6137190
references.citation: J Biol Chem. 1985 Mar 25;260(6):3440-50
references.pmid: 3838314
references.citation: J Biol Chem. 1989 Nov 15;264(32):19458-67
references.pmid: 2478559
references.citation: FEBS Lett. 1990 Jul 30;268(1):79-82
references.pmid: 1696554
references.citation: Biochem J. 1990 Oct 15;271(2):515-22
references.pmid: 2173565
references.citation: J Physiol. 1991 Sep;441:559-73
references.pmid: 1816386
references.citation: Biochem J. 1992 Dec 15;288 ( Pt 3):1025-35
references.pmid: 1281979
references.citation: Biochim Biophys Acta. 1993 Apr 16;1176(3):215-21
references.pmid: 8471623
references.citation: Biochem J. 1994 Aug 15;302 ( Pt 1):187-90
references.pmid: 8068004
references.citation: Pflugers Arch. 1994 Oct;428(5-6):433-8
references.pmid: 7838664
references.citation: Br J Pharmacol. 1994 Nov;113(3):861-8
references.pmid: 7858878
references.citation: Cardiovasc Res. 1995 Feb;29(2):260-8
references.pmid: 7736504
references.citation: J Physiol. 1995 Jun 1;485 ( Pt 2):349-64
references.pmid: 7666363
references.citation: J Biol Chem. 1998 Jan 2;273(1):133-42
references.pmid: 9417057
references.citation: Biochem Biophys Res Commun. 1998 Jan 6;242(1):191-6
references.pmid: 9439634
references.citation: Life Sci. 1998;63(6):499-510
references.pmid: 9718074
references.citation: Biochem J. 1999 Jan 15;337 ( Pt 2):153-69
references.pmid: 9882611
references.citation: Neurosci Lett. 1999 Mar 12;262(3):199-202
references.pmid: 10218890
references.citation: J Pharmacol Exp Ther. 1999 Sep;290(3):1363-8
references.pmid: 10454515
references.citation: Neuropsychopharmacology. 2000 Aug;23(2):188-97
references.pmid: 10882845
references.citation: Circ Res. 2001 Feb 16;88(3):325-32
references.pmid: 11179201
references.citation: Life Sci. 2001 Feb 23;68(14):1593-605
references.pmid: 11263672
references.citation: J Biol Chem. 2001 Apr 20;276(16):13331-9
references.pmid: 11278449
references.citation: Trends Pharmacol Sci. 2001 Jun;22(6):292-7
references.pmid: 11395157
references.citation: Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S61-9
references.pmid: 11518079
references.citation: Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S89-97
references.pmid: 11518084
references.citation: Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S103-7
references.pmid: 11518055
references.citation: Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S111-5
references.pmid: 11518058
references.citation: Biochem J. 2001 Sep 15;358(Pt 3):717-26
references.pmid: 11535132
references.citation: Blood. 2002 Oct 15;100(8):2801-11
references.pmid: 12351388